Status:
RECRUITING
Ketamine Enhances Analgesia and Mood in Chronic Pain Patients
Lead Sponsor:
Salem Anaesthesia Pain Clinic
Conditions:
Mood Disorder; Opioid
Mood Insomnia
Eligibility:
All Genders
20-99 years
Brief Summary
Most chronic pain patients have mood disorders. The mood disorders may improve with better analgesia produced by Ketamine injections. A prospective study of patients undergoing interventional pain the...
Detailed Description
Chronic pain is usually associated with psychological and mood disorders. Many chronic pain patients have various forms of mood abnormalities; and these mood issues may improve with better analgesia p...
Eligibility Criteria
Inclusion
- adult chronic pain patients
- associated mood disorder
- good treatment compliance
- associated chronic insomnia
- regular ketamine pain therapy injection
- consent for clinical record quality assurance review
Exclusion
- severe cognitive disorder
- inability to provide consent
- major neuropsychiatric disorder
- cannabis use
- stimulant use
- substance abuse
- poor treatment compliance
- lack of ketamine pain therapy injection
Key Trial Info
Start Date :
February 2 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05985811
Start Date
February 2 2018
End Date
December 31 2025
Last Update
January 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Salem Anaesthesia Pain Clinic
Surrey, British Columbia, Canada, V3S 7J1